McKesson Corporation (NYSE:MCK) Files An 8-K Regulation FD DisclosureItem 7.01
On June28, 2018, in connection with its Investor Day in Boston, Massachusetts, McKesson Corporation (the “Company”) issued a press release reaffirming its earnings guidance for the fiscal year ending March31, 2019 and is providing preliminary guidance for the fiscal quarter ending June30, 2018. A copy of the Company’s press release is attached hereto as Exhibit 99.1.
The information contained in this Form 8-K, including Exhibit 99.1, is furnished to the Securities and Exchange Commission (the “Commission”), but shall not be deemed “filed” with the Commission for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing.
| Item 7.01 | Financial Statements and Exhibits. |
MCKESSON CORP ExhibitEX-99.1 2 d848749dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 MCKESSON REAFFIRMS FISCAL 2019 GUIDANCE AND PROVIDES PRELIMINARY GUIDANCE FOR THE FIRST QUARTER SAN FRANCISCO—June 28,…To view the full exhibit click here
About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.
